Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 20, 2015 | VP, Technical Operations | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,812 | -- | 42,188 | |
| Mar 20, 2015 | VP, Patient Advocacy | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,812 | -- | 42,188 | |
| Oct 13, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 2,827 | $12.59 | 1,757,175 | |
| Oct 27, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 2,836 | $8.88 | 1,728,311 | |
| Feb 05, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,845 | $10.24 | 459,135 | |
| Feb 05, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,845 | $10.24 | 459,135 | |
| Jun 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 2,855 | $11.45 | 62,336 | |
| Jun 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,855 | $11.45 | 62,336 | |
| Nov 09, 2016 | SVP, Finance | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,858 | $8.00 | 27,047 | |
| Nov 09, 2016 | SVP, Finance | Open market or private sale of non-derivative or derivative security | Form 4 | 2,858 | $8.00 | 24,189 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.